Dow Jones

39,872.99

0.17%

Monitoree múltiples cotizaciones en tiempo real de los principales intercambios, como la Bolsa de Valores de Londres, NASDAQ, NYSE, AMEX, Bovespa y más.

Regístrate

DRTSW

Alpha Tau Medical (DRTSW)

Alpha Tau Medical Ltd

Fecha:

Regulatory News

Text Search:

Ordernar por:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:DRTSW

1 2 Próxima >

Fecha	Hora	Fuente	Título	Símbolo	Compañía
21/05/2024	07:47	Edgar (US Regulatory)	Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]	NASDAQ:DRTSW	Alpha Tau Medical Ltd
21/05/2024	07:45	GlobeNewswire Inc.	Alpha Tau to Present at the Jefferies Global Healthcare Conference	NASDAQ:DRTSW	Alpha Tau Medical Ltd
20/05/2024	15:01	GlobeNewswire Inc.	Alpha Tau Medical Announces First Quarter 2024 Financial Results and Provides Corporate Update	NASDAQ:DRTSW	Alpha Tau Medical Ltd
13/05/2024	07:30	GlobeNewswire Inc.	Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal Cancer	NASDAQ:DRTSW	Alpha Tau Medical Ltd
06/05/2024	07:30	GlobeNewswire Inc.	Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in Glasgow	NASDAQ:DRTSW	Alpha Tau Medical Ltd
01/05/2024	07:30	GlobeNewswire Inc.	Alpha Tau to Participate in May Investor Conferences	NASDAQ:DRTSW	Alpha Tau Medical Ltd
25/03/2024	07:50	GlobeNewswire Inc.	Alpha Tau to Present at the Jefferies Radiopharma Innovation Summit	NASDAQ:DRTSW	Alpha Tau Medical Ltd
07/03/2024	15:01	GlobeNewswire Inc.	Alpha Tau Medical Announces Full Year 2023 Financial Results and Provides Corporate Update	NASDAQ:DRTSW	Alpha Tau Medical Ltd
26/02/2024	07:30	GlobeNewswire Inc.	Alpha Tau to Participate in Barclays 26th Annual Global Healthcare Conference	NASDAQ:DRTSW	Alpha Tau Medical Ltd
20/12/2023	08:15	GlobeNewswire Inc.	Alpha Tau to Present at the 42nd Annual J.P. Morgan Healthcare Conference	NASDAQ:DRTSW	Alpha Tau Medical Ltd
29/11/2023	07:30	GlobeNewswire Inc.	Alpha Tau to Participate in Sidoti Small-Cap Conference	NASDAQ:DRTSW	Alpha Tau Medical Ltd
28/11/2023	07:30	GlobeNewswire Inc.	Alpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic Cancer	NASDAQ:DRTSW	Alpha Tau Medical Ltd
20/11/2023	07:30	GlobeNewswire Inc.	Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck Cancer	NASDAQ:DRTSW	Alpha Tau Medical Ltd
16/11/2023	15:30	GlobeNewswire Inc.	Alpha Tau Medical Announces Third Quarter 2023 Financial Results and Provides Corporate Update	NASDAQ:DRTSW	Alpha Tau Medical Ltd
30/10/2023	07:30	GlobeNewswire Inc.	Alpha Tau Enters Into Long-Term Lease of Site in New Hampshire for Second U.S. Manufacturing Facility	NASDAQ:DRTSW	Alpha Tau Medical Ltd
24/10/2023	08:00	GlobeNewswire Inc.	Former U.S. Commissioner of Food and Drug Administration Stephen M. Hahn, M.D. Appointed to Alpha Tau Advisory Board	NASDAQ:DRTSW	Alpha Tau Medical Ltd
14/09/2023	07:30	GlobeNewswire Inc.	Alpha Tau Treats First Patient with Advanced Inoperable Pancreatic Cancer at Israel’s Hadassah Medical Center	NASDAQ:DRTSW	Alpha Tau Medical Ltd
28/08/2023	15:02	GlobeNewswire Inc.	Alpha Tau Medical Announces Second Quarter 2023 Financial Results and Provides Corporate Update	NASDAQ:DRTSW	Alpha Tau Medical Ltd
17/08/2023	16:00	GlobeNewswire Inc.	Alpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha DaRT	NASDAQ:DRTSW	Alpha Tau Medical Ltd
24/05/2023	15:01	GlobeNewswire Inc.	Alpha Tau Medical to Participate in June Investor Conferences	NASDAQ:DRTSW	Alpha Tau Medical Ltd
23/05/2023	15:01	GlobeNewswire Inc.	Alpha Tau Medical Announces First Quarter 2023 Financial Results and Provides Corporate Update	NASDAQ:DRTSW	Alpha Tau Medical Ltd
17/05/2023	15:30	GlobeNewswire Inc.	Alpha Tau Expands its Alpha DaRT Treatment to Vulvar Cancer in Novel Clinical Trial with Cambridge University	NASDAQ:DRTSW	Alpha Tau Medical Ltd
11/05/2023	15:00	GlobeNewswire Inc.	Alpha Tau Announces the Publication of its US Multicenter Pilot Skin Cancer Trial Results in JAMA Network Open	NASDAQ:DRTSW	Alpha Tau Medical Ltd
03/05/2023	15:00	GlobeNewswire Inc.	Alpha Tau Medical to Present at Guggenheim Radiopharmaceuticals Day	NASDAQ:DRTSW	Alpha Tau Medical Ltd
03/04/2023	08:10	GlobeNewswire Inc.	Alpha Tau and the JGH Announce Alpha DaRT Treatment of First Patient in its Advanced Pancreatic Cancer Clinical Trial	NASDAQ:DRTSW	Alpha Tau Medical Ltd
29/03/2023	15:00	GlobeNewswire Inc.	Alpha Tau Medical to Present at Jefferies Radiopharma Innovation Summit	NASDAQ:DRTSW	Alpha Tau Medical Ltd
12/03/2023	07:30	GlobeNewswire Inc.	Alpha Tau Medical Confirms No Direct Exposure to Silicon Valley Bank	NASDAQ:DRTSW	Alpha Tau Medical Ltd
09/03/2023	15:10	GlobeNewswire Inc.	Alpha Tau Medical Announces Full Year 2022 Financial Results and Provides Corporate Update	NASDAQ:DRTSW	Alpha Tau Medical Ltd
08/03/2023	16:00	GlobeNewswire Inc.	Alpha Tau Announces Alpha DaRT™ Treatment of First Two Patients in its Pivotal Multicenter Recurrent Skin Cancer (ReSTART) Trial	NASDAQ:DRTSW	Alpha Tau Medical Ltd
03/03/2023	07:30	GlobeNewswire Inc.	Alpha Tau Announces Grant of Expanded Radioactive License and Final Pre-Clinical Laboratory Regulatory Approval at its Jerusalem Headquarters	NASDAQ:DRTSW	Alpha Tau Medical Ltd